160 related articles for article (PubMed ID: 29254290)
1. Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Wang XH; Liu YN; Tian K; Yao CX; Li LM; Zheng YQ; Shi ZM
J Biol Regul Homeost Agents; 2017; 31(4):879-887. PubMed ID: 29254290
[TBL] [Abstract][Full Text] [Related]
2. Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells.
Pandey V; Qian PX; Kang J; Perry JK; Mitchell MD; Yin Z; Wu ZS; Liu DX; Zhu T; Lobie PE
Endocrinology; 2010 Mar; 151(3):909-20. PubMed ID: 20118197
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of eukaryotic translation initiation factor and matrix metalloproteinase 9 in endometrial cancer tissue.
Shi ZM; Liu YN; Fu B; Shen YF; Li LM
J Biol Regul Homeost Agents; 2017; 31(4):1053-1059. PubMed ID: 29254314
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase (MMP)-2 and MMP-9 expression in tumor infiltrating CD3 lymphocytes from women with endometrial cancer.
Jedryka M; Chrobak A; Chelmonska-Soyta A; Gawron D; Halbersztadt A; Wojnar A; Kornafel J
Int J Gynecol Cancer; 2012 Oct; 22(8):1303-9. PubMed ID: 22964525
[TBL] [Abstract][Full Text] [Related]
5. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
6. SPOCK2 Affects the Biological Behavior of Endometrial Cancer Cells by Regulation of MT1-MMP and MMP2.
Ren F; Wang D; Wang Y; Chen P; Guo C
Reprod Sci; 2020 Jul; 27(7):1391-1399. PubMed ID: 32430715
[TBL] [Abstract][Full Text] [Related]
7. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.
Karahan N; Güney M; Baspinar S; Oral B; Kapucuoglu N; Mungan T
Eur J Gynaecol Oncol; 2007; 28(3):184-8. PubMed ID: 17624083
[TBL] [Abstract][Full Text] [Related]
8. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
9. The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
Ruan H; Liang X; Zhao W; Ma L; Zhao Y
Biomed Pharmacother; 2017 May; 89():812-818. PubMed ID: 28273643
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of human macrophage metalloelastase (MMP-12) is associated with the invasion of endometrial adenocarcinoma.
Yang X; Dong Y; Zhao J; Sun H; Deng Y; Fan J; Yan Q
Pathol Res Pract; 2007; 203(7):499-505. PubMed ID: 17574772
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the status of DACH1 gene promoter methylation in endometrial carcinoma and its clinical significance].
Deng XC; Li SR; Zhang Q; Zhou CJ; Yang QF; Jiang J; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):263-7. PubMed ID: 22781112
[TBL] [Abstract][Full Text] [Related]
14. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
Guo W; Chen G; Zhu C; Wang H
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):604-7. PubMed ID: 12487935
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and estrogen receptor induce matrix metalloproteinase-26 expression in endometrial carcinoma cells.
Nishi H; Kuroda M; Isaka K
Oncol Rep; 2013 Aug; 30(2):751-6. PubMed ID: 23754174
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
17. Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.
Cioppi F; Simi L; Luciani P; Petraglia F; Susini T; Cobellis L; Serio M; Maggi M; Peri A
Oncol Rep; 2004 Feb; 11(2):427-33. PubMed ID: 14719079
[TBL] [Abstract][Full Text] [Related]
18. Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.
He X; Liao Y; Lu W; Xu G; Tong H; Ke J; Wan X
Tumour Biol; 2016 Jul; 37(7):9951-8. PubMed ID: 26815505
[TBL] [Abstract][Full Text] [Related]
19. beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.
Saegusa M; Hashimura M; Yoshida T; Okayasu I
Br J Cancer; 2001 Jan; 84(2):209-17. PubMed ID: 11161379
[TBL] [Abstract][Full Text] [Related]
20. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]